The Net Margin of Exact Sciences Corporation (EXAS) is
-6.40%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
| Date |
Value |
| 2025-12-31 |
-6.40%
|
| 2024-12-31 |
-37.29%
|
| 2023-12-31 |
-8.17%
|
| 2022-12-31 |
-29.91%
|
| 2021-12-31 |
-33.70%
|
| 2020-12-31 |
-55.22%
|
| 2019-12-31 |
-24.32%
|
| 2018-12-31 |
-38.53%
|
| 2017-12-31 |
-43.01%
|
| 2016-12-31 |
-168.21%
|
| Ticker |
Name |
Value |
|
ORGO
|
Organogenesis Holdings Inc.
|
6.56%
|
|
SRRK
|
Scholar Rock Holding Corporation
|
-405.21%
|
|
BBIO
|
BridgeBio Pharma, Inc.
|
-144.39%
|
|
EXEL
|
Exelixis Inc
|
33.73%
|
|
NTRA
|
Natera, Inc.
|
-9.03%
|
|
ALXN
|
Alexion Pharmaceuticals Inc
|
9.94%
|
|
TWST
|
Twist Bioscience Corporation
|
-28.34%
|
|
PTCT
|
PTC Therapeutics, Inc.
|
39.44%
|
|
ARWR
|
Arrowhead Pharmaceuticals, Inc.
|
-160.64%
|
|
BMRN
|
BioMarin Pharmaceutical Inc.
|
10.83%
|
|
NVAX
|
Novavax, Inc.
|
39.19%
|
|
AGIO
|
Agios Pharmaceuticals, Inc.
|
-764.01%
|
|
VIR
|
Vir Biotechnology, Inc.
|
-638.87%
|
|
CBPO
|
China Biologic Products Holdings Inc
|
29.04%
|
|
SRNE
|
Sorrento Therapeutics Inc
|
-912.10%
|
|
TVTX
|
Travere Therapeutics, Inc.
|
-5.21%
|
|
VCEL
|
Vericel Corporation
|
5.98%
|
|
INSM
|
Insmed Incorporated
|
-210.54%
|
|
NBIX
|
Neurocrine Biosciences, Inc.
|
16.73%
|
|
OPK
|
OPKO Health, Inc.
|
-37.19%
|
|
MYGN
|
Myriad Genetics, Inc.
|
-44.38%
|
|
XNCR
|
Xencor, Inc.
|
-73.20%
|
|
ACAD
|
Acadia Pharmaceuticals Inc.
|
36.49%
|
|
AMRN
|
Amarin Corporation PLC
|
-18.16%
|
|
MORF
|
Morphic Holding Inc
|
-29192.90%
|
|
BCRX
|
BioCryst Pharmaceuticals, Inc.
|
30.16%
|
|
EDIT
|
Editas Medicine, Inc.
|
-395.01%
|